UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 30, 2001
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________to _________
Commission file number 0-19756
PROTEIN DESIGN LABS, INC.
(Exact name of Registrant as specified in its Charter)
34801 Campus Drive
Fremont, California, 94555
(Address of Principal Executive Offices including Zip Code)
(510) 574-1400
(Registrant's Telephone Number, Including Area Code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]
As of July 31, 2001, there were 43,831,630 shares of the Registrant's Common Stock outstanding.
EXPLANATORY NOTE
Protein Design Labs, Inc. is filing this Amendment No. 1 to Form 10-Q as an exhibit-only filing. The Company is refiling Exhibit 10.1, Collaboration Agreement, dated May 22, 2001, by and between Protein Design Labs, Inc. and Exelixis, Inc., and confidential treatment has been requested for certain portions of such exhibit.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its be half by the undersigned thereunto duly authorized.
Dated: September 20, 2001
| PROTEIN DESIGN LABS, INC. |
| (Registrant) |
| By: | /s/ Robert Kirkman |
| Robert Kirkman | |
| Vice President, Business Development and Corporate Communications | |
| (Principal Accounting Officer) |
INDEX TO EXHIBITS
Index Number | Description |
10.1* | Collaboration Agreement between the Company and Exelixis, Inc., a Delaware corporation dated May 22, 2001 (with certain confidential portions deleted and marked by notation indicating such deletion). |
10.2** | Convertible Note between the Company and Exelixis, Inc., a Delaware corporation dated May 22, 2001. |
10.3** | Note Purchase Agreement between the Company and Exelixis, Inc., a Delaware corporation dated May 22, 2001. |
10.4** | Lease Agreement between the Company and St. Paul Properties, Inc., a Delaware corporation, dated May 31, 2001. |
10.5** | Lease Agreement between the Company and John Arrillaga Survivors Trust and the Richard T. Peery Separate Property Trust, a California general partnership, dated June 28, 2001. |
___________
*Filed herewith, and confidential treatment requested for certain portions of this exhibit.
**Previously filed.
